Laura Chang, PhD, is Senior Vice President of Product at Artera, where she leads the company’s product lifecycle, regulatory, and quality teams. With a strong background in oncology and molecular diagnostics, Laura has a proven track record of translating scientific innovation into clinical solutions. Prior to Artera, she served as President of PFS Genomics, a precision medicine startup developing predictive biomarkers to guide radiation therapy in breast cancer. She led the company through its acquisition by Exact Sciences, where she continued to drive integration of the technology into the broader product portfolio. Laura earned her BS, MS, and PhD from the University of Michigan.